Web Resource
Government Resource
Press Release/Announcement

Relenza (zanamivir) inhalation powder.

Food and Drug Administration; FDA.

This alert notifies health care providers of the potential for patient harm if a particular inhalation powder is reconstituted and incorrectly administered.